We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,466
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.2%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDI icon
12351
Reading International Class A
RDI
$36.6M
$39.7K ﹤0.01%
+12,207
New +$41.7K
CANO
12352
DELISTED
Cano Health, Inc.
CANO
$39.7K ﹤0.01%
436
+434
+21,700% +$58.9K
BCAB icon
12353
CALL
BioAtla
BCAB
$5.15M
$39.7K ﹤0.01%
296
-670
-69% -$121K
NM
12354
CALL
DELISTED
Navios Maritime Holdings Inc.
NM
$39.6K ﹤0.01%
21,900
-6,900
-24% -$14.4K
SRAD icon
12355
CALL
Sportradar
SRAD
$4.09B
$39.5K ﹤0.01%
3,400
-18,300
-84% -$213K
SURG icon
12356
PUT
SurgePays
SURG
$7.08M
$39.5K ﹤0.01%
8,800
+8,200
+1,367% +$44.2K
PCH
12357
DELISTED
PotlatchDeltic
PCH
$39.5K ﹤0.01%
798
-1,848
-70% -$86.7K
OZON
12358
CALL
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$39.5K ﹤0.01%
9,400
-81,400
-90% -$342K
PXJ icon
12359
CALL
Invesco Oil & Gas Services ETF
PXJ
$67.1M
$39.4K ﹤0.01%
+1,580
New +$42.1K
ABTS icon
12360
Abits Group
ABTS
$4.24M
$39.4K ﹤0.01%
2,707
-1,310
-33% -$20.4K
SNAX
12361
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
$39.2K ﹤0.01%
+5,391
New +$55K
REFI
12362
PUT
Chicago Atlantic Real Estate Finance
REFI
$260M
$39.2K ﹤0.01%
+2,900
New +$42.4K
SMMT icon
12363
Summit Therapeutics
SMMT
$10.6B
$39.2K ﹤0.01%
22,381
-25,997
-54% -$70.9K
USPH icon
12364
PUT
US Physical Therapy
USPH
$1.21B
$39.2K ﹤0.01%
400
-100
-20% -$9.54K
TBI
12365
PUT
Trueblue
TBI
$311M
$39.2K ﹤0.01%
2,200
-3,400
-61% -$63.6K
VNRX icon
12366
CALL
VolitionRx Ltd
VNRX
$6.89M
$39.2K ﹤0.01%
1,025
-480
-32% -$20.1K
TKC icon
12367
CALL
Turkcell
TKC
$4.75B
$39.1K ﹤0.01%
9,100
+2,700
+42% +$12.3K
FAZE
12368
CALL
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$39K ﹤0.01%
84,700
-198,600
-70% -$170K
AMS icon
12369
American Shared Hospital Services
AMS
$9.97M
$38.9K ﹤0.01%
+13,842
New +$42.7K
APGB.WS
12370
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$38.9K ﹤0.01%
398,390
-133,553
-25% -$21.2K
KAMN
12371
PUT
DELISTED
Kaman Corp
KAMN
$38.9K ﹤0.01%
+1,700
New +$40.5K
PINC
12372
CALL
DELISTED
Premier
PINC
$38.8K ﹤0.01%
1,200
-100
-8% -$3.27K
VNRX icon
12373
VolitionRx Ltd
VNRX
$6.89M
$38.8K ﹤0.01%
1,016
-3,082
-75% -$129K
KNTE
12374
CALL
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$38.8K ﹤0.01%
6,200
+6,000
+3,000% +$36.6K
AMCR icon
12375
PUT
Amcor
AMCR
$21.3B
$38.7K ﹤0.01%
680
-1,240
-65% -$71K

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.